US equities |
MU $1,043.37 ▼-2.04% NVDA $229.20 ▲+0.36% SNDK $1,723.15 ▼-0.96% TSLA $357.90 ▲+0.87% INTC $118.80 ▼-1.19% AMD $607.92 ▼-0.63% GOOGL $340.71 ▼-0.98% LITE $1,063.46 ▲+9.49%
FinancialContent Watchlist

Johnson & Johnson (NY:JNJ)

262.60 -2.14 (-0.81%)
Delayed Quote Updated: 11:14 AM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now ↗
Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs. 
Via The Motley Fool
Topics Intellectual Property
Thursday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
News headline image
Johnson & Johnson Just Got a Big FDA Win ↗
The company's autoimmune drug was approved for the treatment of a rare blood disease. 
Via The Motley Fool
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Standout ↗
Via Chartmill
News headline image
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now ↗
The company is firing on all cylinders. 
Via The Motley Fool
Topics Intellectual Property
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Top dow jones movers in Tuesday's session ↗
Via Chartmill
News headline image
Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment ↗
Johnson & Johnson secured FDA approval for IMAAVY, the first targeted therapy to treat warm autoimmune hemolytic anemia in adults and youth. 
Via Benzinga
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗
These two high-quality dividend payers have had very different fortunes recently. 
Via The Motley Fool
Topics Lawsuit
News headline image
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It. ↗
American States Water has quietly been increasing its dividend for over 70 years. 
Via The Motley Fool
News headline image
VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? ↗
Vanguard offers three dividend ETFs—VIG, VYM, and VYMI—with distinct yields, holdings, and geographic focus, giving income investors varied ways to access dividend-paying stocks. 
Via MarketBeat
Topics ETFs
News headline image
2 Dividend Stocks to Buy and Never Sell ↗
Both of these healthcare leaders are Dividend Kings. 
Via The Motley Fool
Topics Economy
News headline image
If a Stock Market Crash Is Coming, History Says Buying and Holding These Stocks Is a Smart Move ↗
Bear markets are a normal part of investing, so you should always own some stocks that are resilient to market downturns. 
Via The Motley Fool
Topics ETFs Economy
News headline image
3 Dividend Stocks to Buy and Hold for the Next 5 Years ↗
All three are also solid "forever" holdings, but the next five years could be particularly exciting as each company bounces back from recent challenges. 
Via The Motley Fool
Topics Economy
News headline image
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗
IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk. 
Via The Motley Fool
Topics ETFs
Discover which dow jones stocks are making waves on Friday. ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Friday. ↗
Via Chartmill
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
News headline image
Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future ↗
Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgrade ↗
Johnson & Johnson secures FDA clearance for MONARCH QUEST 3 software, boosting robotic bronchoscopy accuracy with AI. new 3D imaging tools. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Warren Buffett Thinks Investors Are "Gambling" and "Playing With Fire" Right Now. But Here Are 3 Safe Stocks Even the Oracle of Omaha Would Like. ↗
While investors treat Wall Street like a casino, stick to these Buffett-style "wonderful investments." 
Via The Motley Fool
News headline image
Thinking About Buying SpaceX? These 2 Stocks Should Be Better Bets ↗
The space company is popular right now, but these other corporations look more attractive. 
Via The Motley Fool
Topics Artificial Intelligence World Trade
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
Which dow jones stocks are moving on Tuesday? ↗
Via Chartmill
Discover which dow jones stocks are making waves on Monday. ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >